Sun Pharma Advanced Research Company has informed that, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and the Company’s Code of Conduct for Prevention of Insider Trading (‘the CoC’), the Trading Window for trading in shares of the Company by Designated Persons (alongwith their immediate relatives and/or persons with whom they share material financial relationship), will be closed with effect from Saturday, April 01, 2023 till 48 hours after the declaration of Audited Financial Results of the Company for the quarter and year ending on March 31, 2023. The date of Board Meeting for declaration of the Audited Financial Results of the Company for the quarter and year ending on March 31, 2023 will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 435.70 |
| Indegene | 486.80 |
| CMS Info Systems | 318.00 |
| JITF Infralogistics | 338.00 |
| Sagility | 42.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: